BACKGROUND: Rotavirus gastroenteritis is a major cause of mortality among children <2 years of age. Disease burden data are important for introducing and sustaining new rotavirus vaccines in immunization programs. METHODS: We analyzed population-based infectious disease surveillance data from 2007 to 2010 from Kenyan sites in rural and urban slum areas. Stool specimens were collected from patients of all ages presenting to study clinics with diarrheal disease and tested for rotavirus by enzyme immunoassay. Incidence rates were adjusted using data on healthcare utilization (from biweekly home visits) and proportion of stools collected at study clinics from patients meeting case definitions. RESULTS: Rotavirus was detected in 285 (9.0%) of 3174 stools tested, including 122 (11.9%) from children <5 years of age and 162 (7.6%) from participants ≥5 years of age. Adjusted incidence rates for infants were 13,419 and 12,135 per 100,000 person-years of observation in rural and urban areas, respectively. Adjusted incidence rates were high in adults across age ranges. The rates suggest that annually, among children <5 years of age, there are >54,500 cases of rotavirus-associated gastroenteritis in rural Nyanza Province and >16,750 cases in Nairobi urban slums. CONCLUSIONS: Community-based surveillance in urban and rural Kenya suggests that rotavirus plays an important role as a cause of acute gastroenteritis in adults, as well as in children. In addition to substantially preventing illness and complications from diarrheal disease in children, rotavirus infant immunization has the potential of indirectly preventing diarrheal disease in older children and adults, assuming children are the predominant sources of transmission.
BACKGROUND:Rotavirus gastroenteritis is a major cause of mortality among children <2 years of age. Disease burden data are important for introducing and sustaining new rotavirus vaccines in immunization programs. METHODS: We analyzed population-based infectious disease surveillance data from 2007 to 2010 from Kenyan sites in rural and urban slum areas. Stool specimens were collected from patients of all ages presenting to study clinics with diarrheal disease and tested for rotavirus by enzyme immunoassay. Incidence rates were adjusted using data on healthcare utilization (from biweekly home visits) and proportion of stools collected at study clinics from patients meeting case definitions. RESULTS: Rotavirus was detected in 285 (9.0%) of 3174 stools tested, including 122 (11.9%) from children <5 years of age and 162 (7.6%) from participants ≥5 years of age. Adjusted incidence rates for infants were 13,419 and 12,135 per 100,000 person-years of observation in rural and urban areas, respectively. Adjusted incidence rates were high in adults across age ranges. The rates suggest that annually, among children <5 years of age, there are >54,500 cases of rotavirus-associated gastroenteritis in rural Nyanza Province and >16,750 cases in Nairobi urban slums. CONCLUSIONS: Community-based surveillance in urban and rural Kenya suggests that rotavirus plays an important role as a cause of acute gastroenteritis in adults, as well as in children. In addition to substantially preventing illness and complications from diarrheal disease in children, rotavirus infant immunization has the potential of indirectly preventing diarrheal disease in older children and adults, assuming children are the predominant sources of transmission.
Authors: Evan J Anderson; Ben Z Katz; Jennifer A Polin; Susheel Reddy; Melissa H Weinrobe; Gary A Noskin Journal: J Infect Date: 2011-09-16 Impact factor: 6.072
Authors: George E Armah; Samba O Sow; Robert F Breiman; Michael J Dallas; Milagritos D Tapia; Daniel R Feikin; Fred N Binka; A Duncan Steele; Kayla F Laserson; Nana A Ansah; Myron M Levine; Kristen Lewis; Michele L Coia; Margaret Attah-Poku; Joel Ojwando; Stephen B Rivers; John C Victor; Geoffrey Nyambane; Abraham Hodgson; Florian Schödel; Max Ciarlet; Kathleen M Neuzil Journal: Lancet Date: 2010-08-06 Impact factor: 79.321
Authors: E Pozio; G Rezza; A Boschini; P Pezzotti; A Tamburrini; P Rossi; M Di Fine; C Smacchia; A Schiesari; E Gattei; R Zucconi; P Ballarini Journal: J Infect Dis Date: 1997-10 Impact factor: 5.226
Authors: Daniel R Feikin; Beatrice Olack; Godfrey M Bigogo; Allan Audi; Leonard Cosmas; Barrack Aura; Heather Burke; M Kariuki Njenga; John Williamson; Robert F Breiman Journal: PLoS One Date: 2011-01-18 Impact factor: 3.240
Authors: Umesh D Parashar; Erik G Hummelman; Joseph S Bresee; Mark A Miller; Roger I Glass Journal: Emerg Infect Dis Date: 2003-05 Impact factor: 6.883
Authors: Henry N Njuguna; Leonard Cosmas; John Williamson; Dhillon Nyachieo; Beatrice Olack; John B Ochieng; Newton Wamola; Joseph O Oundo; Daniel R Feikin; Eric D Mintz; Robert F Breiman Journal: PLoS One Date: 2013-03-07 Impact factor: 3.240
Authors: Richard Omore; Jacqueline E Tate; Ciara E O'Reilly; Tracy Ayers; John Williamson; Feny Moke; Katie A Schilling; Alex O Awuor; Peter Jaron; John B Ochieng; Joseph Oundo; Umesh D Parashar; Michele B Parsons; Cheryl C Bopp; Dilruba Nasrin; Tamer H Farag; Karen L Kotloff; James P Nataro; Sandra Panchalingam; Myron M Levine; Kayla F Laserson; J Pekka Nuorti; Eric D Mintz; Robert F Breiman Journal: PLoS One Date: 2016-08-05 Impact factor: 3.240
Authors: Richard Omore; Sammy Khagayi; Billy Ogwel; Reuben Onkoba; John B Ochieng; Jane Juma; Stephen Munga; Collins Tabu; Sergon Kibet; J Pekka Nuorti; Frank Odhiambo; Jason M Mwenda; Robert F Breiman; Umesh D Parashar; Jacqueline E Tate Journal: BMC Infect Dis Date: 2019-01-11 Impact factor: 3.090
Authors: Kayoko Shioda; Leonard Cosmas; Allan Audi; Nicole Gregoricus; Jan Vinjé; Umesh D Parashar; Joel M Montgomery; Daniel R Feikin; Robert F Breiman; Aron J Hall Journal: PLoS One Date: 2016-04-26 Impact factor: 3.240